{"entity":{"type":"insider","cik":"0001604763","url":"/insider/0001604763","json_url":"/insider/0001604763.json","name":"Schatzman Randall C","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":31,"n_filings":17,"first":"2015-01-28","last":"2024-02-06","span_basis":"filed_date"},"name_variants":[{"name":"Schatzman Randall C","source":"filing","n_filings":17,"first_seen":"2015-01-28","last_seen":"2024-02-06"}],"transactions":[{"id":2037817,"accession":"0001209191-24-002897","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-24-002897","line_url":"/filing/0001209191-24-002897#line-2","is_derivative":false,"issuer_cik":"0001604763","issuer_name":"Bolt Biotherapeutics, Inc.","issuer_ticker":"BOLT","issuer_name_source":null,"issuer_url":"/issuer/0001604763","owner_cik":"0001604763","owner_name":"Schatzman Randall C","owner_display_name":"Schatzman Randall C","owner_url":"/insider/0001604763","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2500.0,"shares_display":"2,500","price_per_share":0.782,"price_display":"0.78","price_state":"stated","total_value":1955.0,"total_display":"1,955.00","total_whole":"1,955","shares_owned_after":12859.0,"shares_owned_after_display":"12,859","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-12-06","filed_date":"2024-02-06","scope":"insider"},{"id":2037816,"accession":"0001209191-24-002897","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-24-002897","line_url":"/filing/0001209191-24-002897#line-1","is_derivative":false,"issuer_cik":"0001604763","issuer_name":"Bolt Biotherapeutics, Inc.","issuer_ticker":"BOLT","issuer_name_source":null,"issuer_url":"/issuer/0001604763","owner_cik":"0001604763","owner_name":"Schatzman Randall C","owner_display_name":"Schatzman Randall C","owner_url":"/insider/0001604763","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2500.0,"shares_display":"2,500","price_per_share":1.1815,"price_display":"1.18","price_state":"stated","total_value":2953.75,"total_display":"2,953.75","total_whole":"2,954","shares_owned_after":10359.0,"shares_owned_after_display":"10,359","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-06-06","filed_date":"2024-02-06","scope":"insider"},{"id":7949033,"accession":"0001209191-23-007575","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-23-007575","line_url":"/filing/0001209191-23-007575#line-2","is_derivative":false,"issuer_cik":"0001604763","issuer_name":"Bolt Biotherapeutics, Inc.","issuer_ticker":"BOLT","issuer_name_source":null,"issuer_url":"/issuer/0001604763","owner_cik":"0001604763","owner_name":"Schatzman Randall C","owner_display_name":"Schatzman Randall C","owner_url":"/insider/0001604763","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2500.0,"shares_display":"2,500","price_per_share":1.1815,"price_display":"1.18","price_state":"stated","total_value":2953.75,"total_display":"2,953.75","total_whole":"2,954","shares_owned_after":7859.0,"shares_owned_after_display":"7,859","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-12-06","filed_date":"2023-02-07","scope":"insider"},{"id":7949029,"accession":"0001209191-23-007575","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-007575","line_url":"/filing/0001209191-23-007575#line-1","is_derivative":false,"issuer_cik":"0001604763","issuer_name":"Bolt Biotherapeutics, Inc.","issuer_ticker":"BOLT","issuer_name_source":null,"issuer_url":"/issuer/0001604763","owner_cik":"0001604763","owner_name":"Schatzman Randall C","owner_display_name":"Schatzman Randall C","owner_url":"/insider/0001604763","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2500.0,"shares_display":"2,500","price_per_share":1.6405,"price_display":"1.64","price_state":"stated","total_value":4101.25,"total_display":"4,101.25","total_whole":"4,101","shares_owned_after":5359.0,"shares_owned_after_display":"5,359","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-06-06","filed_date":"2023-02-07","scope":"insider"},{"id":5393743,"accession":"0001209191-21-008739","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-21-008739","line_url":"/filing/0001209191-21-008739#line-1","is_derivative":false,"issuer_cik":"0001604763","issuer_name":"Bolt Biotherapeutics, Inc.","issuer_ticker":"BOLT","issuer_name_source":null,"issuer_url":"/issuer/0001604763","owner_cik":"0001604763","owner_name":"Schatzman Randall C","owner_display_name":"Schatzman Randall C","owner_url":"/insider/0001604763","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1500.0,"shares_display":"1,500","price_per_share":20.0,"price_display":"20.00","price_state":"stated","total_value":30000.0,"total_display":"30,000.00","total_whole":"30,000","shares_owned_after":1500.0,"shares_owned_after_display":"1,500","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-02-09","filed_date":"2021-02-09","scope":"insider"},{"id":4410893,"accession":"0001209191-17-010156","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-17-010156","line_url":"/filing/0001209191-17-010156#line-2","is_derivative":false,"issuer_cik":"0001423824","issuer_name":"ALDER BIOPHARMACEUTICALS INC","issuer_ticker":"ALDR","issuer_name_source":null,"issuer_url":"/issuer/0001423824","owner_cik":"0001604763","owner_name":"Schatzman Randall C","owner_display_name":"Schatzman Randall C","owner_url":"/insider/0001604763","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":30000.0,"shares_display":"30,000","price_per_share":25.0252,"price_display":"25.03","price_state":"stated","total_value":750756.0,"total_display":"750,756.00","total_whole":"750,756","shares_owned_after":115172.0,"shares_owned_after_display":"115,172","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-02-09","filed_date":"2017-02-13","scope":"insider"},{"id":2834918,"accession":"0001209191-16-149146","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-16-149146","line_url":"/filing/0001209191-16-149146#line-2","is_derivative":false,"issuer_cik":"0001423824","issuer_name":"ALDER BIOPHARMACEUTICALS INC","issuer_ticker":"ALDR","issuer_name_source":null,"issuer_url":"/issuer/0001423824","owner_cik":"0001604763","owner_name":"Schatzman Randall C","owner_display_name":"Schatzman Randall C","owner_url":"/insider/0001604763","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":25.1605,"price_display":"25.16","price_state":"stated","total_value":251605.0,"total_display":"251,605.00","total_whole":"251,605","shares_owned_after":114768.0,"shares_owned_after_display":"114,768","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-11-07","filed_date":"2016-11-09","scope":"insider"},{"id":3217063,"accession":"0001209191-16-145134","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-16-145134","line_url":"/filing/0001209191-16-145134","is_derivative":false,"issuer_cik":"0001423824","issuer_name":"ALDER BIOPHARMACEUTICALS INC","issuer_ticker":"ALDR","issuer_name_source":null,"issuer_url":"/issuer/0001423824","owner_cik":"0001604763","owner_name":"Schatzman Randall C","owner_display_name":"Schatzman Randall C","owner_url":"/insider/0001604763","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8181.0,"shares_display":"8,181","price_per_share":31.146638943894388,"price_display":"31.15","price_state":"stated","total_value":254810.6532,"total_display":"254,810.65","total_whole":"254,811","shares_owned_after":117468.0,"shares_owned_after_display":"117,468","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-10-03","filed_date":"2016-10-05","scope":"insider","n_lines":2},{"id":2668045,"accession":"0001209191-16-140250","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-16-140250","line_url":"/filing/0001209191-16-140250#line-2","is_derivative":false,"issuer_cik":"0001423824","issuer_name":"ALDER BIOPHARMACEUTICALS INC","issuer_ticker":"ALDR","issuer_name_source":null,"issuer_url":"/issuer/0001423824","owner_cik":"0001604763","owner_name":"Schatzman Randall C","owner_display_name":"Schatzman Randall C","owner_url":"/insider/0001604763","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":32.482,"price_display":"32.48","price_state":"stated","total_value":324820.0,"total_display":"324,820.00","total_whole":"324,820","shares_owned_after":114768.0,"shares_owned_after_display":"114,768","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-09-01","filed_date":"2016-09-06","scope":"insider"},{"id":2250684,"accession":"0001209191-16-135311","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-16-135311","line_url":"/filing/0001209191-16-135311","is_derivative":false,"issuer_cik":"0001423824","issuer_name":"ALDER BIOPHARMACEUTICALS INC","issuer_ticker":"ALDR","issuer_name_source":null,"issuer_url":"/issuer/0001423824","owner_cik":"0001604763","owner_name":"Schatzman Randall C","owner_display_name":"Schatzman Randall C","owner_url":"/insider/0001604763","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":31.15133456,"price_display":"31.15","price_state":"stated","total_value":311513.3456,"total_display":"311,513.35","total_whole":"311,513","shares_owned_after":119600.0,"shares_owned_after_display":"119,600","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-08-01","filed_date":"2016-08-03","scope":"insider","n_lines":3},{"id":2179992,"accession":"0001209191-16-134184","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-16-134184","line_url":"/filing/0001209191-16-134184#line-2","is_derivative":false,"issuer_cik":"0001423824","issuer_name":"ALDER BIOPHARMACEUTICALS INC","issuer_ticker":"ALDR","issuer_name_source":null,"issuer_url":"/issuer/0001423824","owner_cik":"0001604763","owner_name":"Schatzman Randall C","owner_display_name":"Schatzman Randall C","owner_url":"/insider/0001604763","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":28.0805,"price_display":"28.08","price_state":"stated","total_value":280805.0,"total_display":"280,805.00","total_whole":"280,805","shares_owned_after":114768.0,"shares_owned_after_display":"114,768","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-07-25","filed_date":"2016-07-27","scope":"insider"},{"id":2318378,"accession":"0001209191-16-125846","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-16-125846","line_url":"/filing/0001209191-16-125846","is_derivative":false,"issuer_cik":"0001423824","issuer_name":"ALDER BIOPHARMACEUTICALS INC","issuer_ticker":"ALDR","issuer_name_source":null,"issuer_url":"/issuer/0001423824","owner_cik":"0001604763","owner_name":"Schatzman Randall C","owner_display_name":"Schatzman Randall C","owner_url":"/insider/0001604763","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":29.65438415,"price_display":"29.65","price_state":"stated","total_value":296543.8415,"total_display":"296,543.84","total_whole":"296,544","shares_owned_after":116733.0,"shares_owned_after_display":"116,733","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-06-01","filed_date":"2016-06-03","scope":"insider","n_lines":2},{"id":2996982,"accession":"0001209191-16-123086","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001209191-16-123086","line_url":"/filing/0001209191-16-123086#line-6","is_derivative":false,"issuer_cik":"0001423824","issuer_name":"ALDER BIOPHARMACEUTICALS INC","issuer_ticker":"ALDR","issuer_name_source":null,"issuer_url":"/issuer/0001423824","owner_cik":"0001604763","owner_name":"Schatzman Randall C","owner_display_name":"Schatzman Randall C","owner_url":"/insider/0001604763","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4017.0,"shares_display":"4,017","price_per_share":28.0278,"price_display":"28.03","price_state":"stated","total_value":112587.6726,"total_display":"112,587.67","total_whole":"112,588","shares_owned_after":112947.0,"shares_owned_after_display":"112,947","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-05-24","filed_date":"2016-05-24","scope":"insider"},{"id":2996978,"accession":"0001209191-16-123086","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-16-123086","line_url":"/filing/0001209191-16-123086#line-4","is_derivative":false,"issuer_cik":"0001423824","issuer_name":"ALDER BIOPHARMACEUTICALS INC","issuer_ticker":"ALDR","issuer_name_source":null,"issuer_url":"/issuer/0001423824","owner_cik":"0001604763","owner_name":"Schatzman Randall C","owner_display_name":"Schatzman Randall C","owner_url":"/insider/0001604763","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2997.0,"shares_display":"2,997","price_per_share":28.012,"price_display":"28.01","price_state":"stated","total_value":83951.964,"total_display":"83,951.96","total_whole":"83,952","shares_owned_after":112947.0,"shares_owned_after_display":"112,947","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-05-23","filed_date":"2016-05-24","scope":"insider"},{"id":2996973,"accession":"0001209191-16-123086","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-16-123086","line_url":"/filing/0001209191-16-123086#line-2","is_derivative":false,"issuer_cik":"0001423824","issuer_name":"ALDER BIOPHARMACEUTICALS INC","issuer_ticker":"ALDR","issuer_name_source":null,"issuer_url":"/issuer/0001423824","owner_cik":"0001604763","owner_name":"Schatzman Randall C","owner_display_name":"Schatzman Randall C","owner_url":"/insider/0001604763","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2986.0,"shares_display":"2,986","price_per_share":28.0091,"price_display":"28.01","price_state":"stated","total_value":83635.1726,"total_display":"83,635.17","total_whole":"83,635","shares_owned_after":112947.0,"shares_owned_after_display":"112,947","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-05-20","filed_date":"2016-05-24","scope":"insider"},{"id":2995993,"accession":"0001209191-16-114604","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001209191-16-114604","line_url":"/filing/0001209191-16-114604#line-7","is_derivative":false,"issuer_cik":"0001423824","issuer_name":"ALDER BIOPHARMACEUTICALS INC","issuer_ticker":"ALDR","issuer_name_source":null,"issuer_url":"/issuer/0001423824","owner_cik":"0001604763","owner_name":"Schatzman Randall C","owner_display_name":"Schatzman Randall C","owner_url":"/insider/0001604763","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4514.0,"shares_display":"4,514","price_per_share":28.0775,"price_display":"28.08","price_state":"stated","total_value":126741.835,"total_display":"126,741.84","total_whole":"126,742","shares_owned_after":112947.0,"shares_owned_after_display":"112,947","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-04-18","filed_date":"2016-04-18","scope":"insider"},{"id":2995982,"accession":"0001209191-16-114604","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001209191-16-114604","line_url":"/filing/0001209191-16-114604#line-5","is_derivative":false,"issuer_cik":"0001423824","issuer_name":"ALDER BIOPHARMACEUTICALS INC","issuer_ticker":"ALDR","issuer_name_source":null,"issuer_url":"/issuer/0001423824","owner_cik":"0001604763","owner_name":"Schatzman Randall C","owner_display_name":"Schatzman Randall C","owner_url":"/insider/0001604763","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":14024.0,"shares_display":"14,024","price_per_share":28.1054,"price_display":"28.11","price_state":"stated","total_value":394150.1296,"total_display":"394,150.13","total_whole":"394,150","shares_owned_after":112947.0,"shares_owned_after_display":"112,947","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-04-15","filed_date":"2016-04-18","scope":"insider"},{"id":2995967,"accession":"0001209191-16-114604","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-16-114604","line_url":"/filing/0001209191-16-114604#line-2","is_derivative":false,"issuer_cik":"0001423824","issuer_name":"ALDER BIOPHARMACEUTICALS INC","issuer_ticker":"ALDR","issuer_name_source":null,"issuer_url":"/issuer/0001423824","owner_cik":"0001604763","owner_name":"Schatzman Randall C","owner_display_name":"Schatzman Randall C","owner_url":"/insider/0001604763","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11462.0,"shares_display":"11,462","price_per_share":28.0121,"price_display":"28.01","price_state":"stated","total_value":321074.6902,"total_display":"321,074.69","total_whole":"321,075","shares_owned_after":112947.0,"shares_owned_after_display":"112,947","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-04-14","filed_date":"2016-04-18","scope":"insider"},{"id":2655207,"accession":"0001209191-16-090199","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-16-090199","line_url":"/filing/0001209191-16-090199","is_derivative":false,"issuer_cik":"0001423824","issuer_name":"ALDER BIOPHARMACEUTICALS INC","issuer_ticker":"ALDR","issuer_name_source":null,"issuer_url":"/issuer/0001423824","owner_cik":"0001604763","owner_name":"Schatzman Randall C","owner_display_name":"Schatzman Randall C","owner_url":"/insider/0001604763","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":31.4747,"price_display":"31.47","price_state":"stated","total_value":314747.0,"total_display":"314,747.00","total_whole":"314,747","shares_owned_after":113599.0,"shares_owned_after_display":"113,599","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-01-04","filed_date":"2016-01-06","scope":"insider","n_lines":2},{"id":8228039,"accession":"0001209191-15-083416","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-15-083416","line_url":"/filing/0001209191-15-083416#line-2","is_derivative":false,"issuer_cik":"0001423824","issuer_name":"ALDER BIOPHARMACEUTICALS INC","issuer_ticker":"ALDR","issuer_name_source":null,"issuer_url":"/issuer/0001423824","owner_cik":"0001604763","owner_name":"Schatzman Randall C","owner_display_name":"Schatzman Randall C","owner_url":"/insider/0001604763","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":37.2431,"price_display":"37.24","price_state":"stated","total_value":372431.0,"total_display":"372,431.00","total_whole":"372,431","shares_owned_after":111579.0,"shares_owned_after_display":"111,579","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-12-01","filed_date":"2015-12-03","scope":"insider"},{"id":8803658,"accession":"0001209191-15-078573","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-15-078573","line_url":"/filing/0001209191-15-078573","is_derivative":false,"issuer_cik":"0001423824","issuer_name":"ALDER BIOPHARMACEUTICALS INC","issuer_ticker":"ALDR","issuer_name_source":null,"issuer_url":"/issuer/0001423824","owner_cik":"0001604763","owner_name":"Schatzman Randall C","owner_display_name":"Schatzman Randall C","owner_url":"/insider/0001604763","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":33.70664048,"price_display":"33.71","price_state":"stated","total_value":337066.4048,"total_display":"337,066.40","total_whole":"337,066","shares_owned_after":109921.0,"shares_owned_after_display":"109,921","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-11-02","filed_date":"2015-11-04","scope":"insider","n_lines":3},{"id":8942934,"accession":"0001209191-15-047660","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-15-047660","line_url":"/filing/0001209191-15-047660#line-2","is_derivative":false,"issuer_cik":"0001423824","issuer_name":"ALDER BIOPHARMACEUTICALS INC","issuer_ticker":"ALDR","issuer_name_source":null,"issuer_url":"/issuer/0001423824","owner_cik":"0001604763","owner_name":"Schatzman Randall C","owner_display_name":"Schatzman Randall C","owner_url":"/insider/0001604763","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":50000.0,"shares_display":"50,000","price_per_share":38.9617,"price_display":"38.96","price_state":"stated","total_value":1948085.0,"total_display":"1,948,085.00","total_whole":"1,948,085","shares_owned_after":109921.0,"shares_owned_after_display":"109,921","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-05-26","filed_date":"2015-05-28","scope":"insider"},{"id":8407175,"accession":"0001209191-15-007124","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-15-007124","line_url":"/filing/0001209191-15-007124#line-2","is_derivative":false,"issuer_cik":"0001423824","issuer_name":"ALDER BIOPHARMACEUTICALS INC","issuer_ticker":"ALDR","issuer_name_source":null,"issuer_url":"/issuer/0001423824","owner_cik":"0001604763","owner_name":"Schatzman Randall C","owner_display_name":"Schatzman Randall C","owner_url":"/insider/0001604763","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":63578.0,"shares_display":"63,578","price_per_share":28.7075,"price_display":"28.71","price_state":"stated","total_value":1825165.435,"total_display":"1,825,165.44","total_whole":"1,825,165","shares_owned_after":109921.0,"shares_owned_after_display":"109,921","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-01-27","filed_date":"2015-01-28","scope":"insider"},{"id":8407172,"accession":"0001209191-15-007124","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-15-007124","line_url":"/filing/0001209191-15-007124#line-1","is_derivative":false,"issuer_cik":"0001423824","issuer_name":"ALDER BIOPHARMACEUTICALS INC","issuer_ticker":"ALDR","issuer_name_source":null,"issuer_url":"/issuer/0001423824","owner_cik":"0001604763","owner_name":"Schatzman Randall C","owner_display_name":"Schatzman Randall C","owner_url":"/insider/0001604763","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":36422.0,"shares_display":"36,422","price_per_share":27.9291,"price_display":"27.93","price_state":"stated","total_value":1017233.6802,"total_display":"1,017,233.68","total_whole":"1,017,234","shares_owned_after":173499.0,"shares_owned_after_display":"173,499","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-01-26","filed_date":"2015-01-28","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":31,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":5,"open_market":true},{"code":"S","label":"Open-market sale","n":26,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":31},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001641281","name":"Bolt Biotherapeutics, Inc.","url":"/issuer/0001641281","role":"Director, Officer (Chief Executive Officer)","n_filings":3,"first_seen":"2021-02-09","last_seen":"2024-02-06"},{"type":"issuer","type_label":"ISSUER","cik":"0001423824","name":"ALDER BIOPHARMACEUTICALS INC","url":"/issuer/0001423824","role":"Director, Officer (President and CEO)","n_filings":14,"first_seen":"2015-01-28","last_seen":"2017-02-13"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001604763","retrieved_at":"2026-08-22T08:23:29+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}